Workflow
三嗪酰胺
icon
Search documents
停牌,多只A股集体公告
Zheng Quan Shi Bao· 2025-09-28 23:41
Group 1: Control Change Announcements - Asia Pacific Pharmaceutical announced that its controlling shareholder is planning a change in company control, leading to a stock suspension starting September 29, with an expected duration of no more than 2 trading days [2] - Multiway Pharmaceutical also announced a similar control change plan, resulting in a stock suspension from September 29, with an expected duration of no more than 2 trading days [3] - Zhonghuan Environmental Protection's controlling shareholder is also planning a control change, leading to a stock suspension from September 29, with an expected duration of no more than 2 trading days [3][4] Group 2: Financial Performance - Asia Pacific Pharmaceutical reported a revenue of 152 million yuan for the first half of the year, a year-on-year decrease of 31.48%, while net profit attributable to shareholders was 105 million yuan, an increase of 1820.97% [2] - Multiway Pharmaceutical's revenue for the first half was 107 million yuan, down 29.13%, with a net loss of 42.5 million yuan compared to a loss of 3.28 million yuan in the previous year [3] - Zhonghuan Environmental Protection achieved a revenue of 474 million yuan in the first half, a year-on-year increase of 4.84%, with a net profit of 44.09 million yuan, up 9.69% [4] Group 3: Asset Acquisition Plans - Zhiguang Electric is planning to acquire all or part of the minority equity of its subsidiary, Guangzhou Zhiguang Energy Technology Co., Ltd., through a combination of share issuance and cash payment, with a stock suspension starting September 29, expected to last no more than 10 trading days [6] - Yidao Information is planning to acquire the controlling stakes in Guangzhou Langguo Electronic Technology Co., Ltd. and Shenzhen Chengwei Information Co., Ltd. through share issuance and cash payment, with a stock suspension starting September 29, expected to last no more than 10 trading days [8]
3家A股公司,同日停牌筹划“易主”
财联社· 2025-09-28 13:06
今日晚间, 多瑞医药(301075.SZ)、中环环保(300692.SZ)、亚太药业(002370.SZ)三家A股上市公司相继发布公告,宣布因控股 股东及实际控制人正在筹划控制权变更事项,公司股票将自9月29日起停牌。 多瑞医药在今日公告中称,控股股东西藏嘉康时代科技发展有限公司、实际控制人邓勇先生正在筹划公司控制权变更相关事宜,该事项可能 导致公司控股股东、实际控制人发生变更。 中环环保主要业务为市政工程项目,包括市政污水、工业废水处理、黑臭水体、湿地治理等水环境治理,以及垃圾焚烧发电、城乡垃圾资源 化处理、危废无害化处置、污泥资源化处理等。 上半年,中环环保公司营业总收入为4.74亿元,同比增长4.84%,归母净利润为4409.10万元,同比增长9.69%。2022年,公司以出资 1200万美元方式投资美国Proof公司,切入氢燃料电池领域。 不过,该公司在本月的调研纪要中披露,因美国外国投资委员会(CFIUS)启动了对公司投资事项的主动审查,已与公司签订相关协议,将 电池技术从Proof公司剥离,公司不能投资该电池技术及相关产品,但仍可继续参与催化加热器技术投资及产品商业化。目前合作建厂未有 新进展。 ...